InvestorsHub Logo
icon url

drv17

01/11/17 3:32 PM

#87422 RE: kld2 #87418

Please read the post closely. It was Falconeer that posted that statement on his post #83059 where he took issue with Feuerstein calling posters here profoundly stupid. Please review his background and posts.
I (drv17) am not debating anyone.
icon url

McMagyar

01/11/17 4:07 PM

#87432 RE: kld2 #87418

Valued at $25?
This company's lead compound alone may be valued above $30 billion in market cap based on Biogen false flag run up.. and that was just one IND- Alzheimer's.
The minimum valuation for Anavex is $50 billion (or $1000 per share) with Sigmaceptor platform,
A3-71 et al.. drug assets, and current SOC -15 month stabilization ( maybe reversal) for Alzheimer's . Not including other possible IND's

All that makes the $1 estimate is more sickeningly wrong than those selling Anavex at $170 million...